Longo DL - Search Results

1

Role for CD40-CD40 ligand interactions in the immune response to solid tumours.

Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL, Murphy WJ, James K, Taub DD. Alexandroff AB, et al. Among authors: longo dl. Mol Immunol. 2000 Jun;37(9):515-26. doi: 10.1016/s0161-5890(00)00079-1. Mol Immunol. 2000. PMID: 11163401

2

Chemokines and T lymphocyte activation: I. Beta chemokines costimulate human T lymphocyte activation in vitro.

Taub DD, Turcovski-Corrales SM, Key ML, Longo DL, Murphy WJ. Taub DD, et al. Among authors: longo dl. J Immunol. 1996 Mar 15;156(6):2095-2103. J Immunol. 1996. PMID: 8690897

3

Differential in vitro and in vivo antitumor effects mediated by anti-CD40 and anti-CD20 monoclonal antibodies against human B-cell lymphomas.

Funakoshi S, Longo DL, Murphy WJ. Funakoshi S, et al. Among authors: longo dl. J Immunother Emphasis Tumor Immunol. 1996 Mar;19(2):93-101. doi: 10.1097/00002371-199603000-00002. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8732692

4

Effects of CD40 stimulation in the prevention of human EBV-lymphomagenesis.

Funakoshi S, Taub DD, Asai O, Hirano A, Ruscetti FW, Longo DL, Murphy WJ. Funakoshi S, et al. Among authors: longo dl. Leuk Lymphoma. 1997 Jan;24(3-4):187-99. doi: 10.3109/10428199709039007. Leuk Lymphoma. 1997. PMID: 9156649 Review.

5

CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras.

Murphy WJ, Funakoshi S, Fanslow WC, Rager HC, Taub DD, Longo DL. Murphy WJ, et al. Among authors: longo dl. Clin Immunol. 1999 Jan;90(1):22-7. doi: 10.1006/clim.1998.4632. Clin Immunol. 1999. PMID: 9884349

6

Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand.

Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC, Murphy WJ. Hirano A, et al. Among authors: longo dl. Blood. 1999 May 1;93(9):2999-3007. Blood. 1999. PMID: 10216096 Free article.

7

Epstein-Barr virus-induced human B-cell lymphoma arising in HuPBL-SCID chimeric mice: characterization and the role of CD40 stimulation in their treatment and prevention.

Funakoshi S, Beckwith M, Fanslow W, Longo DL, Murphy WJ. Funakoshi S, et al. Among authors: longo dl. Pathobiology. 1995;63(3):133-42. doi: 10.1159/000163944. Pathobiology. 1995. PMID: 8821629

8

The huPBL-SCID mouse as a means to examine human immune function in vivo.

Murphy WJ, Taub DD, Longo DL. Murphy WJ, et al. Among authors: longo dl. Semin Immunol. 1996 Aug;8(4):233-41. doi: 10.1006/smim.1996.0029. Semin Immunol. 1996. PMID: 8883146 Review.

9

Immunologic and hematopoietic effects of CD40 stimulation after syngeneic bone marrow transplantation in mice.

Funakoshi S, Taub DD, Anver MR, Raziuddin A, Asai O, Reddy V, Rager H, Fanslow WC, Longo DL, Murphy WJ. Funakoshi S, et al. Among authors: longo dl. J Clin Invest. 1997 Feb 1;99(3):484-91. doi: 10.1172/JCI119183. J Clin Invest. 1997. PMID: 9022082 Free PMC article.

10

Induction of alloantigen-specific T cell tolerance through the treatment of human T lymphocytes with wortmannin.

Taub DD, Murphy WJ, Asai O, Fenton RG, Peltz G, Key ML, Turcovski-Corrales S, Longo DL. Taub DD, et al. Among authors: longo dl. J Immunol. 1997 Mar 15;158(6):2745-55. J Immunol. 1997. PMID: 9058809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

792 results

Search Page

Filters